Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Preprints

Bliuc D; Tran TT; Chen W; Alarkawi D; Alajlouni DA; Blyth F; March L; Ensrud K; Blank RD; Center JR, 2022, The Contribution of Multimorbidity to Under-Diagnosis and Under-Treatment of Osteoporosis in High-Risk Fracture Patients, http://dx.doi.org/10.2139/ssrn.4105592

Alajlouni DA; Tran T; Bliuc D; Blank RD; Cawthon PM; Orwoll E; Center JR, 2021, Muscle Strength and Physical Performance Improve Fracture Risk Prediction Beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study, http://dx.doi.org/10.2139/ssrn.3916776

Lee NJ; Ali N; Zhang L; Qi Y; Clarke I; Enriquez RF; Brzozowska M; Lee IC; Rogers MJ; Laybutt DR; Center JR; Baldock PA; Herzog H, 2018, Osteoglycin: A Novel Coordinator of Bone and Glucose Homeostasis, http://dx.doi.org/10.2139/ssrn.3155778

Orford NR; Bone A; Kotowicz MA; Bailey M; Pasco JA; Maiden M; Kakho N; Cattigan C; Nichonghaile M; Jones C; Hodgson C; Nair P; Center J; Bellomo R, A pilot trial of the effect of bone antiresorptive agents on bone turnover markers in critically ill women, http://dx.doi.org/10.21203/rs.3.rs-3284440/v1

Munoz MA; Fletcher EK; Skinner OP; Jurczyluk J; Kristianto E; Hodson MP; Sun S; Ebetino FH; Croucher DR; Hansbro PM; Center JR; Rogers MJ, Bisphosphonate drugs have actions outside the skeleton and inhibit the mevalonate pathway in alveolar macrophages, http://dx.doi.org/10.1101/2021.08.09.455652

Alajlouni DA; Bliuc D; Tran TT; Blank RD; Center JR, Muscle Strength and Physical Performance Contribute to and Improve Fracture Risk Prediction in Older People: A Narrative Review, http://dx.doi.org/10.2139/ssrn.4281657

Gration B; Chai RC; Young SG; Sergio CM; Skorokhodova E; Smith JT; Castro-Martinez A; Bray A; Lin X; Yan C; Kao J; Perram J; Lai S; Lau L; Weilbaecher KN; Moore J; Pocock N; Chaffer CL; Center J; Phan TG; McCaughan G; Croucher PI, Romosozumab Safely Restores Bone Mass in Multiple Myeloma via Osteoblast Reprogramming: A Phase IIa Study, http://dx.doi.org/10.64898/2026.07.02.26357196

Tran T; Ho-Le T; Bliuc D; Abrahamsen B; Hansen L; Vestergaard P; Center JR; Nguyen TV, Skeletal Age for mapping the impact of fracture on mortality, http://dx.doi.org/10.1101/2022.09.09.22279789


Back to profile page